The symposium titled, “Actinium-225 Targeted Radionuclide Therapy – Current Perspective and Future Outlooks” will take place on June 25, from 11:30 am to 12:55 pm CET. Participants can attend in person or join via live stream, which will be available on the TWC website ahead of the congress.
The event will feature expert speakers, Prof. Matthias Eiber, Associate Professor, Clinic and Polyclinic for Nuclear Medicine, Klinikum rechts der Isar, TU Munich, Prof. Katharina Lückerath, Preclinical Theranostics, Clinic for Nuclear Medicine, University Hospital Essen and Neil Quigley, Global Product Manager at ITM.
Programm 6th Theranostics World Congress
An Evaluation of Current and Prospective 225Ac Production Methods
Neil Quigley, Global Product Manager, ITM, Garching / Munich
225Ac-PSMA for the Treatment of Prostate Cancer – Preclinical Experience
Prof. Katharina Lückerath, University Hospital Essen
Current Clinical Experience for 225Ac-PSMA in mCRPC
Prof. Matthias Eiber, Klinikum rechts der Isar, Technical University of Munich
